A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma
Clinical trial NCT01975519 · COMPLETED
Trial details
- NCT number
- NCT01975519
- Sponsor
- Tracon Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-10
- Primary completion
- 2019-03-11
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.